AI assistant
Sending…
Cytosorbents Corp — Director's Dealing 2012
Dec 3, 2012
34501_dirs_2012-12-03_ab41f5ac-9493-4aa2-a91f-6afc53f592dd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cytosorbents Corp (CTSO)
CIK: 0001175151
Period of Report: 2012-11-28
Reporting Person: Bocchino Thomas (Chief Financial Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $0.12 | 2017-11-28 | Common Stock (1000000) | Direct |
Footnotes
F1: 500,000 options exercisable on 11/28/2013 and 500,000 options exercisable on 11/28/2014.
More from Cytosorbents Corp
Annual Report
2026
Apr 15
Delisting Announcement
2026
Apr 2
Annual Report
2026
Mar 30
Earnings Release
2026
Mar 25
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2025
Nov 21
Earnings Release
2025
Nov 13
Interim / Quarterly Report
2025
Nov 13
Delisting Announcement
2025
Oct 3
Regulatory Filings
2025
Sep 16